XML 38 R14.htm IDEA: XBRL DOCUMENT v2.4.0.8
STOCKHOLDERS' EQUITY
 6 Months Ended
Dec. 31, 2013
STOCKHOLDERS' EQUITY [Abstract]  
STOCKHOLDERS' EQUITY
NOTE 6: - STOCKHOLDERS' EQUITY
 
From July 2013 through December 2013, a total of 1,685,154 warrants were exercised via "cashless" exercise, resulting in the issuance of 1,023,474 shares of common stock to investors of the Company.  In addition, 919,000 warrants were exercised for cash and resulted in the issuance of 919,000 shares of common stock to investors of the Company. The aggregate cash consideration received was $1,179. In August 2013, a total of 15,000 warrants were exercised via a "cashless" exercise, resulting in the issuance of 5,905 shares of common stock to a consultant of the Company. Additionally, in October 2013, 1,500 options were exercised by a consultant, resulting in an issuance of 1,500 shares of common stock.
 
 
a.
Options, warrants and restricted stock units to employees, directors and consultants:
 
 
1.
Options to employees and directors:
 
The Company has approved two incentive option plans from 2003 and from 2005 (the "2003 Plan" and the "2005 Plan", and collectively, the "Plans").

The Company accounted for its options to employees and directors in accordance with ASC 718, "Compensation - Stock Compensation". A summary of the Company's share option activity for options granted to employees and directors under the Plans is as follows:

   
Six months ended December 31, 2013 (Unaudited)
  
   
Number
    
Weighted Average Exercise Price
    
Weighted Average Remaining Contractual Terms (in years)
    
Aggregate Intrinsic Value Price
  
Options outstanding at beginning of period
     1,958,156     $ 4.01              
Options forfeited
     (81,057 )   $ 11.59              
Options outstanding at end of the period
     1,877,099     $ 3.70       3.63     $ 1,273  
Options exercisable at the end of the period
     1,877,099     $ 3.70       3.63     $ 1,273  
Options vested
     1,877,099     $ 3.70       3.63     $ 1,273  
 
Intrinsic value of exercisable options (the difference between the Company's closing stock price on the last trading day in the period and the exercise price, multiplied by the number of in-the-money options) represents the amount that would have been received by the employees and directors option holders had all option holders exercised their options on December 31, 2013. This amount changes based on the fair market value of the Company's common stock.
 

 
2.
Options and warrants to non-employees:

A summary of the Company's activity related to options and warrants to consultants is as follows:

   
Six months ended December 31, 2013 (Unaudited)
  
   
Number
    
Weighted Average Exercise Price
    
Weighted Average Remaining Contractual Terms (in years)
    
Aggregate Intrinsic Value Price
  
Options and warrants outstanding at beginning of period
     315,500     $ 4.40              
Options and warrants exercised
     (16,500 )   $ 1.74              
Options and warrants outstanding at end of the period
     299,000     $ 4.59       3.70     $ 484  
                                 
Options and warrants exercisable at the end of the period
     299,000     $ 4.59       3.70     $ 484  
                                 
Options and warrants vested and expected to vest
     299,000     $ 4.59       3.70     $ 494  
 
Compensation expenses related to options and warrants granted to consultants were recorded as follows:
 
   
Six months ended December 31,
    
Three months ended December 31,
  
   
2013
    
2012
    
2013
    
2012
  
Research and development expenses
   $ 2     $ -     $ -     $ -  
General and administrative expenses
     -       21       -       3  
    $ 2     $ 21     $ -     $ 3  

 
 
 
3.
Restricted stock units to employees and directors:
 
During the six month period ended December 31, 2013, the Company granted restricted stock units to several of the Company's employees and directors.
 
The following table summarizes the activities for unvested restricted stock units granted to employees and directors for the six months ended December 31, 2013 (Unaudited):
 
   
Number
  
Unvested at the beginning of period
     1,660,525  
Granted
     695,000  
Forfeited
     (32,573 )
Vested
     (746,027 )
Unvested at the end of the period
     1,576,925  
Expected to vest after  December 31, 2013
     1,569,216  
 
Compensation expenses related to restricted stock units granted to employees and directors were recorded as follows:
 
   
Six months ended December 31,
    
Three months ended December 31,
  
   
2013
    
2012
    
2013
    
2012
  
Research and development expenses
   $ 214     $ 481     $ 88     $ 164  
General and administrative expenses
     2,103       1,028       1,055       420  
    $ 2,317     $ 1,509     $ 1,143     $ 584  
 
 
Future expenses related to restricted stock units granted to employees and directors for an average time of approximately 2 years is $3,716.
 

 
 
4.
Restricted stock units to consultants:
 
During the six month period ended December 31, 2013, the Company granted restricted stock units to several consultants and service providers.
 
The following table summarizes the activities for unvested restricted stock units granted to consultants for the six months ended December 31, 2013:
 
   
Number
  
Unvested at the beginning of period
     -  
Granted
     29,160  
Forfeited
     -  
Vested
     -  
Unvested at the end of the period
     29,160  
Expected to vest after December 31, 2013
     29,160  
 
Compensation expenses related to restricted stock units granted to consultants were recorded as follows:
 
   
Six months ended December 31,
    
Three months ended December 31,
  
   
2013
    
2012
    
2013
    
2012
  
Research and development expenses
   $ 17     $ 154     $ 16     $ 34  
General and administrative expenses
     -       278       -       5  
    $ 17     $ 432     $ 16     $ 39